A mass spectrometry-based test of blood serum protein biomarkers for CRC detection showed a panel consisting of four proteins (CD44, GC, CRP, and ITIH3) showed the highest efficacy in differentiating regional from localized cancers, yet not in predicting CRC occurrence compared to cancer-free individuals (99). This evidence concerns the gene CRP and cancer.